Brown Brothers Harriman & Co’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Brown Brothers Harriman & Co’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-284	Closed	-$2K	–	1273
2020 Q1	$2K	Hold	284	–	–	﹤0.01%	965
2019 Q4	$7K	Hold	284	–	–	﹤0.01%	951
2019 Q3	$8K	Sell	284 -106	-27%	-$2.98K	﹤0.01%	933
2019 Q2	$11K	Buy	390 +106	+37%	+$3.32K	﹤0.01%	816
2019 Q1	$10K	Hold	284	–	–	﹤0.01%	848
2018 Q4	$6K	Hold	284	–	–	﹤0.01%	778
2018 Q3	$8K	Hold	284	–	–	﹤0.01%	711
2018 Q2	$11K	Hold	284	–	–	﹤0.01%	659
2018 Q1	$9K	Hold	284	–	–	﹤0.01%	677
2017 Q4	$14K	Hold	284	–	–	﹤0.01%	715
2017 Q3	$15K	Hold	284	–	–	﹤0.01%	629
2017 Q2	$16K	Sell	284 -283	-50%	-$11.3K	﹤0.01%	620
2017 Q1	$22K	Sell	567 -77	-12%	-$2.45K	﹤0.01%	582
2016 Q4	$14K	Buy	644 +567	+736%	+$11.1K	﹤0.01%	671
2016 Q3	$2K	Hold	77	–	–	﹤0.01%	757
2016 Q2	$2K	Buy	+77	New	+$1.9K	﹤0.01%	801

Other funds holding PTLA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return

Brown Brothers Harriman & Co's PTLA Position: Q2 2020 in Review

Brown Brothers Harriman & Co sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 284 shares — an estimated $2K sold.

Brown Brothers Harriman & Co first reported a position in PTLA in Q2 2016 and held it in 16 quarters. The position peaked at $22K in Q1 2017. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

Brown Brothers Harriman & Co reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Brown Brothers Harriman & Co sold 284 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $2K.
Brown Brothers Harriman & Co first reported a position in Portola Pharmaceuticals, Inc. in Q2 2016 and held it in 16 quarters.
Brown Brothers Harriman & Co's Portola Pharmaceuticals, Inc. position peaked at $22K in Q1 2017.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2020, filed 13 Aug 2020.